首页> 美国卫生研究院文献>Cell Cycle >The SWI/SNF ATPase BRG1 stimulates DNA end resection and homologous recombination by reducing nucleosome density at DNA double strand breaks and by promoting the recruitment of the CtIP nuclease
【2h】

The SWI/SNF ATPase BRG1 stimulates DNA end resection and homologous recombination by reducing nucleosome density at DNA double strand breaks and by promoting the recruitment of the CtIP nuclease

机译:SWI / SNF ATP酶BRG1通过降低DNA双链中的核心密度并通过促进CTIP核酸酶的募集来刺激DNA结束切除和同源重组

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

DNA double strand breaks (DSBs) are among the most toxic DNA lesions and can be repaired accurately through homologous recombination (HR). HR requires processing of the DNA ends by nucleases (DNA end resection) in order to generate the required single-stranded DNA (ssDNA) regions. The SWI/SNF chromatin remodelers are 10–15 subunit complexes that contain one ATPase (BRG1 or BRM). Multiple subunits of these complexes have recently been identified as a novel family of tumor suppressors. These complexes are capable of remodeling chromatin by pushing nucleosomes along the DNA. More recent studies have identified these chromatin remodelers as important factors in DNA repair. Using the DR-U2OS reporter system, we show that the down regulation of BRG1 significantly reduces HR efficiency, while BRM has a minor effect. Inactivation of BRG1 impairs DSB repair and results in a defect in DNA end resection, as measured by the amount of BrdU-containing ssDNA generated after DNA damage. Inactivation of BRG1 also impairs the activation of the ATR kinase, reduces the levels of chromatin-bound RPA, and reduces the number of RPA and RAD51 foci after DNA damage. This defect in DNA end resection is explained by the defective recruitment of GFP-CtIP to laser-induced DSBs in the absence of BRG1. Importantly, we show that BRG1 reduces nucleosome density at DSBs. Finally, inactivation of BRG1 renders cells sensitive to anti-cancer drugs that induce DSBs. This study identifies BRG1 as an important factor for HR, which suggests that BRG1-mutated cancers have a DNA repair vulnerability that can be exploited therapeutically.
机译:DNA双链断裂(DSB)是最有毒的DNA病变之一,并且可以通过同源重组(HR)精确修复。 HR需要通过核酸酶(DNA结束切除)处理DNA末端,以产生所需的单链DNA(SSDNA)区域。 SWI / SNF染色质重塑剂是10-15个亚基配合物,其含有一个ATP酶(BRG1或BRM)。最近已鉴定出这些配合物的多个亚基被鉴定为新颖的肿瘤抑制剂系列。这些配合物能够通过推动沿DNA的核体来改造染色质。最近的研究已经将这些染色质重塑者鉴定为DNA修复中的重要因素。使用DR-U2OS记者系统,我们表明BRG1的下调显着降低了人力资源效率,而BRM则效果很小。 BRG1的失活损害DSB修复并导致DNA结束切除缺陷,通过DNA损伤后产生的Brdu的SSDNA的量测量。 BRG1的失活也损害了ATR激酶的激活,减少了染色质的RPA水平,并在DNA损伤后降低了RPA和RAD51焦点的数量。 DNA结束切除中的这种缺陷由GFP-CTIP对激光诱导的DSB的缺陷募集来解释在没有BRG1的情况下。重要的是,我们表明BRG1降低了DSBS的核心密度。最后,BRG1的灭活使细胞对诱导DSB的抗癌药物敏感。该研究将BRG1鉴定为人力资源的一个重要因素,这表明BRG1突变的癌症具有可治疗的DNA修复脆弱性。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号